2026
article
OpenAlex
Giulia Ferrannini, Tymon Pol, Charlotta Ljungman, Ulf Dahlström et autres
AIMS: The interactions between heart failure (HF), chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), and relative drug use remain poorly studied. METHODS: Patients enrolled in the Swedish HF registry 2017-2023 were divided according to CKD and T2DM. HF medication use …
se, it
(code pays fourni par la source)
2026
article
OpenAlex
Sebastian Völz, Pétur Pétursson, Bjorn Redfors, Truls Råmunddal et autres
BACKGROUND: Cardiogenic shock remains the leading cause of in-hospital death in patients with acute myocardial infarction (MI). The intra-aortic balloon pump (IABP), once widely used, was downgraded in European guidelines after a major randomized trial showed no mortality benefit. This prospective observational …
se, dk
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Sara Bentzel, Tobias Andersson, Charlotta Ljungman, Jonathan S.M. Johansson et autres
Aims: To study associations between prediabetes, type 2 diabetes (T2D) and insulin resistance with incident atrial fibrillation (AF) in patients with hypertension. Methods: Patients with hypertension but no AF between 2006 and 2010 were identified in the Swedish Primary Care Cardiovascular Database. …
se
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Federica Guidetti, Lars Christian; id_orcid 0000-0001-8651-6072 Lund, Lina Benson, Camilla Hage et autres
BACKGROUND: A valid definition of severe heart failure (HF) is essential for earlier identification, timely referral for advanced therapies, and to optimize clinical trial design. OBJECTIVES: To assess the prevalence, prognostic performance, and 1-year outcomes associated with different definitions of severe and …
ch, se, it, fr, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Federica Guidetti, Lars H Lund, Lina Benson, Camilla Hage et autres
Background A valid definition of severe heart failure (HF) is essential for earlier identification, timely referral for advanced therapies, and to optimize clinical trial design.Objectives To assess the prevalence, prognostic performance, and 1-year outcomes associated with different definitions of severe and advanced …
at
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Peder L. Myhre, Felix Lindberg, Brian Bridal Løgstrup, Inga Jóna Ingimarsdóttir et autres
This review evaluates the role of heart failure (HF) registries in the Nordic countries-Sweden, Denmark, Norway, and Iceland-in the implementation of the European Society of Cardiology's guidelines for guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF). It critically …
no, se, dk, is, fr, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Christian Basile, C Polte, Piero Gentile, Entela Bollano et autres
Despite its low diagnostic yield, endomyocardial biopsy (EMB) remains the gold standard for establishing a definitive diagnosis in many cardiomyopathies. We developed and validated a machine-learning-based score to predict the likelihood of diagnostic EMB using non-invasive data. We retrospectively analyzed 775 heart …
se, it, gb
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Jonathan S M Johansson, Josefin Henrysson, Carmen Basic, John G F Cleland et autres
BACKGROUND: Iron deficiency (ID) is common in patients with heart failure (HF). Current guidelines define ID based on serum ferritin and transferrin saturation (TSAT) rather than soluble transferrin receptor (STFR) or ratios such as iron/STFR or TSAT/STFR. We investigated the associations between …
se, gb
(code pays fourni par la source)
2025
article
OpenAlex
Felix Lindberg, Charlotta Ljungman, Camilla Hage, Lena Olsson et autres
A growing number of pharmacological and device-based therapies are available to improve well-being and prognosis for patients with heart failure. The increasing complexity of the treatment algorithm also makes implementation of optimal therapy challenging for the healthcare system and the physician. Recent …
se
(code pays fourni par la source)
2025
article
OpenAlex
Jan‐Erik Johansson, Josefin Henrysson, Carmen Basic, J G Cleland et autres
Abstract Background Iron deficiency (ID) is a common comorbidity in heart failure (HF) with current guidelines defining it based on ferritin and transferrin saturation (TSAT). It is not fully understood which biomarker of ID is most strongly correlated with worse prognosis. Additionally, …
se
(code pays fourni par la source)
2025
article
OpenAlex
Carmen Basic, P Karstrom, J Spaak, Pär Parén et autres
Abstract Background Patients with heart failure with reduced ejection fraction (HFrEF) are highly morbid, with the key therapy mineralocorticoid receptor antagonists (MRA) often limited by hyperkalemia (HK). Many patients on suboptimal MRA doses are not titrated due to concerns for HK. Sodium …
se, gb
(code pays fourni par la source)
2025
article
OpenAlex
Sara Bentzel, T Andersson, Charlotta Ljungman, J Johansson et autres
Abstract Background Type 2 diabetes (T2D) exists in one out of four patients with atrial fibrillation (AF). It is, however, unclear whether prediabetes or T2D are risk factors of incident AF. Purpose To study the impact of prediabetes and T2D on incident …
se, us, gb
(code pays fourni par la source)